Serum miR-21 is a diagnostic and prognostic marker of primary central nervous system lymphoma

Primary CNS lymphoma: a clinician’s guide

(2012) Niklas Schäfer et al.   Expert Review of Neurotherapeutics

MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma

(2012) Alexander Baraniskin et al.   JOURNAL OF NEURO-ONCOLOGY

Resection of PCNSL, if safely possible, seems to be better than biopsy: challenging a paradigm?

(2012) R. Nishikawa   NEURO-ONCOLOGY

Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma

(2012) Xinlong Ma et al.   NEURO-ONCOLOGY

Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center

(2012) M. R. Welch et al.   NEURO-ONCOLOGY

MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity

(2012) N. M. Teplyuk et al.   NEURO-ONCOLOGY

Surgery for primary CNS lymphoma? Challenging a paradigm

(2012) M. Weller et al.   NEURO-ONCOLOGY

Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system

(2011) A. Baraniskin et al.   BLOOD

Cognitive functions in primary CNS lymphoma after single or combined modality regimens

(2011) D. D. Correa et al.   NEURO-ONCOLOGY

Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma

(2011) A. Baraniskin et al.   NEURO-ONCOLOGY